Content about Monoclonal antibodies

May 15, 2013
FDA approves J&J's Simponi for ulcerative colitis

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

April 16, 2013
J&J sales rise in first quarter 2013

Johnson & Johnson's sales increased by 8.5% to $17.5 billion in first quarter 2013, the healthcare products company said Tuesday.

April 5, 2013
GSK tests lupus drug in patients with inflammatory blood vessel disorder

GlaxoSmithKline has started a late-stage clinical trial of a drug in patients with an inflammatory disease that affects the blood vessels.

March 27, 2013
FDA approves new MS drug

The Food and Drug Administration has approved a new treatment for multiple sclerosis made by Biogen Idec, the agency said.

February 26, 2013
Reports: Elan not responding to acquisition offer from Royalty Pharma

A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan Corp., but hasn't heard back from it, according to published reports.

February 8, 2013
Elan sells Tysabri rights to Biogen Idec

Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.

February 8, 2013
Reports: Amgen plans six biosimilars

Biotech drug maker Amgen plans to launch six biosimilar drugs starting in 2017, according to published reports.

January 8, 2013
Abbott spins off new drug company

Abbott Labs has spun off its specialty drug division into a new company called AbbVie, which the new company's leaders heralded Wednesday by ringing the first opening bell of 2013 at the New York Stock Exchange.

December 6, 2012
J&J subsidiary seeks new approval for psoriasis drug

Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

November 29, 2012
Eclipsing off-patent Lipitor, Humira tops Rx sales list

Just how much of an impact the loss of patent protection can have on a blockbuster drug became clear earlier this year.


November 13, 2012
Abbott drug shows improvement in young adults with arthritis

Patients with a form of arthritis that affects young people taking a drug made by Abbott experienced improvements in their condition after a year of treatment, according to late-stage clinical trial results.

September 28, 2012
FDA approves Abbott's Humira for ulcerative colitis

The Food and Drug Administration has approved a drug made by Abbott for treating ulcerative colitis.

August 29, 2012
Abbott's Humira gets support for expanded use

A panel of outside advisers to the Food and Drug Administration has backed wider use for Abbott Labs’ rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.

August 23, 2012
J&J, GSK start phase-3 trial program for rheumatoid arthritis drug

A division of Johnson & Johnson has started a late-stage clinical trial program for a drug for rheumatoid arthritis under a partnership with British drug maker GlaxoSmithKline.

August 13, 2012
FDA approves Genentech's Lucentis for diabetic macular edema

Regulators have approved a biotech drug made by Genentech for treating a complication related to diabetes.

August 6, 2012
FDA approves Sanofi drug for colorectal cancer

The Food and Drug Administration has approved a new drug for treating colorectal cancer that has spread to other parts of the body, the agency said Friday.

July 27, 2012
FDA panel recommends new approval for Genentech eye drug

A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

July 17, 2012
J&J seeks approval for Simponi in ulcerative colitis

A subsidiary of Johnson & Johnson is hoping to win an additional approval for one of its drugs.

July 16, 2012
GlaxoSmithKline to acquire Human Genome Sciences for $3.6 billion

British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.

July 9, 2012
FDA approves Lilly, BMS drug for KRAS wild-type colorectal cancer

The Food and Drug Administration has approved a drug made by Eli Lilly and Bristol-Myers Squibb for treating a form of colorectal cancer, the two companies said.

May 24, 2012
Patients with ulcerative colitis respond to Simponi, study finds

Findings from a new study indicate that more than half of the patients with ulcerative colitis who received subcutaneous injections of a drug used to treat autoimmune disorders responded to the treatment.

April 30, 2012
Reports: Dying woman's plea prompts early release of cancer drug

An online plea for help from a mother dying of breast cancer prompted the manufacturer of an experimental drug to release it early, according to published reports.

April 25, 2012
Reports: GSK calls $2.6 billion offer for Human Genome Sciences 'full and fair'

GlaxoSmithKline said its offer to buy Human Genome Sciences was "full and fair" Wednesday after HGS turned it down last week, according to published reports.

April 11, 2012
Reports: Humira to become top-selling drug this year

Move over, Lipitor: There's a new top drug on the market, according to published reports.

March 30, 2012
Genentech announces results of cancer drug trial

Breast cancer patients taking an experimental drug made by Roche subsidiary Genentech lived significantly longer than those taking another drug made by GlaxoSmithKline, according to results of a late-stage clinical trial.

© 2013 Drug Store News. All Rights Reserved.